Author:
Kijima Yuko,Yoshinaka Heiji,Hirata Munetsugu,Nakajo Akihiro,Arima Hideo,Shinden Yoshiaki,Ijichi Tetsuya,Eguchi Yuka,Okumura Hiroshi,Uenosono Yoshikazu,Kurahara Hiroshi,Ishigami Sumiya,Natsugoe Shoji
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Fox SB, Generali DG, Harris AL. Breast tumour angiogenesis. Breast Cancer Res. 2007;9:216.
2. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth in vivo. Nature. 1993;362(6423):841–4.
3. Sweeney CJ, Miller KD, Sissons SE, Nozaki S, Heilman DK, Shen J, Sledge GW Jr. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. Cancer Res. 2001;61(8):3369–72.
4. Burkart CM, Grisel JJ, Hom DB. Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy. Laryngoscope. 2008;118(9):1539–41.
5. Ruiz N, Fernandez Martos C, Romero I, Pla A, Maiquez J, Calatrava A, Guillem V. Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancer. J Clin Oncol. 2007;25(22):3376–7.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献